Showing results (1301-1310 of 2,031) with videos related to

Sort By:
Pageof 204
Environmental Health Perspectives|October 1, 1976
Clinical studies of styrene workers: initial findingsW V Lorimer, R Lilis, W J Nicholson, et al.
Synapse (New York, N.Y.)|November 9, 2000
Opioid peptide receptor studies. 14. Stereochemistry determines agonist efficacy and intrinsic efficacy in the [(35)S]GTP-gamma-S functional binding assayH Xu, A Hashimoto, K C Rice, et al.
British Journal of Obstetrics and Gynaecology|June 1, 1993
A randomised prospective study comparing the new vacuum extractor policy with forceps deliveryR B Johanson, C Rice, M Doyle, et al.
Scientific Reports|November 8, 2016
Novel Toll-like receptor-4 antagonist (+)-naloxone protects mice from inflammation-induced preterm birthPeck Yin Chin, Camilla L Dorian, Mark R Hutchinson, et al.
Shock (Augusta, Ga.)|December 20, 2015
Fecal Microbiota Transplant Restores Mucosal Integrity in a Murine Model of Burn InjuryJoshua W Kuethe, Stephanie M Armocida, Emily F Midura, et al.
Addiction Biology|December 6, 2014
Linear pharmacokinetics of 3,4-methylenedioxypyrovalerone (MDPV) and its metabolites in the rat: relationship to pharmacodynamic effectsSebastien Anizan, Marta Concheiro, Kurt R Lehner, et al.
European Journal of Pharmacology|August 29, 1989
Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypesR B Rothman, C P France, V Bykov, et al.
Scandinavian Journal of Pain|February 28, 2020
Meta-analysis comparing placebo responses in clinical trials of painful HIV-associated sensory neuropathy and diabetic polyneuropathyHarriet I Kemp, Joseph Eliahoo, Lene Vase, et al.
The Clinical Journal of Pain|January 25, 2020
Adherence to Consolidated Standards of Reporting Trials (CONSORT) Guidelines for Reporting Safety Outcomes in Trials of Medical Cannabis and Cannabis-based Medicines for Chronic Noncancer Pain: A Systematic ReviewMohammed M Mohiuddin, Glenio B Mizubuti, Simon Haroutounian, et al.
Journal of Medicinal Chemistry|June 1, 1986
Probes for narcotic receptor mediated phenomena. 12. cis-(+)-3-Methylfentanyl isothiocyanate, a potent site-directed acylating agent for delta opioid receptors. Synthesis, absolute configuration, and receptor enantioselectivityT R Burke, A E Jacobson, K C Rice, et al.
Pageof 204